Repression of SHP-1 Expression by p53 leads to trkA Tyrosine Phosphorylation and Suppression of Breast Cancer Cell Proliferation

Montano, Ximena 2009. Repression of SHP-1 Expression by p53 leads to trkA Tyrosine Phosphorylation and Suppression of Breast Cancer Cell Proliferation. Oncogene. 28, pp. 3787-3800. https://doi.org/10.1038/onc.2009.143

TitleRepression of SHP-1 Expression by p53 leads to trkA Tyrosine Phosphorylation and Suppression of Breast Cancer Cell Proliferation
TypeJournal article
AuthorsMontano, Ximena
Abstract

The nerve growth factor (NGF) receptor, trkA, the tumour suppressor p53 and the phosphatase SHP-1 are critical in cell proliferation and differentiation. SHP-1 is a trkA phosphatase that dephosphorylates trkA at tyrosines (Y) 674 and 675. p53 can induce trkA activation and tyrosine phosphorylation in the absence of NGF stimulation. In breast cancer tumours trkA expression is associated with increased patient survival. TrkA protein expression is higher in breast-cancer cell lines than in normal breast epithelia. In cell lines (but not in normal breast epithelia) trkA is functional and can be NGF-stimulated to promote cell proliferation. This study investigates the functional relationship between trkA, p53 and SHP-1 in breast-cancer, and reveals that in wild-type (wt) trkA expressing breast-cancer cells both endogenous wtp53, activated by therapeutic agents, and transfected wtp53 repress expression of SHP-1 through the proximal CCAAT sequence of the SHP-1-P1-promoter and the transcription factor NF-Y. In these cells trkA-Y674/Y675 phosphorylation is detected when SHP-1 protein levels decrease in a wtp53-dependent manner. Proliferation and cell-cycle assays, with cells expressing endogenous or transfected wt-trkA and a temperature-sensitive p53 grown at 32 °C (when p53 is in the wt configuration), show suppressed cell proliferation. Suppression is not detected when grown at 37 °C (when p53 is in the mutant configuration). A release from suppression is observed when these cells are transiently transfected with wt-SHP-1 and grown at 32 °C. Suppression is also detected when, as control, wt-trkA-expressing cells are transiently transfected with SHP-1-siRNA, but not when a dominant-negative (DN) mutant trkA is used to abolish wt-trkA activity. Importantly, suppression is not seen with control trkA-negative breast-cancer cells (expressing wtp53, wt-SHP-1 and undetectable trkA), transfected with Y674F/Y675F mutant-trkA. BrdU-incorporation experiments reveal lack of incorporation in cells expressing wt-trkA and wtp53, or wt-trkA and SHP-1-siRNA. However, BrdU is incorporated in the presence of Y674F/Y675F mutant trkA or DN mutant trkA. These results indicate that p53 repression of SHP-1 expression leads to trkA-Y674/Y675 phosphorylation and trkA-dependent suppression of breast-cancer cell proliferation. These data provide an explanation as to why high trkA levels are associated with favourable prognosis.

JournalOncogene
Journal citation28, pp. 3787-3800
ISSN1476-5594
0950-9232
Year2009
PublisherNature Publishing Group
Digital Object Identifier (DOI)https://doi.org/10.1038/onc.2009.143
Publication dates
Published14 Sep 2009

Related outputs

Preprint: SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB as potential prognostic and infection biomarkers in neuroblastoma
Brandon Bergsneider, Elise Bailey, Yusuf Ahmed, Namrata Gogineni, Derek Huntley and Ximena Montano 2024. Preprint: SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB as potential prognostic and infection biomarkers in neuroblastoma. Authorea. https://doi.org/10.22541/au.170666000.06060674/v1

A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma Patients
Currie, David, Wong, Nicole, Zane, Isabelle, Rix, Tom, Vardakastanis, Marios, Claxton, Amelia, Ong, Karine K. V., Macmorland, William, Poivet, Arthur, Brooks, Anthony, Niola, Paola, Huntley, Derek and Montano, Ximena 2024. A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma Patients. Cancers. 16 (4) 722. https://doi.org/10.3390/cancers16040722

Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma
Bergsneider, B., Bailey, E., Ahmed, Y., Gogineni, N., Huntley, D. and Montano Hernandez, X. 2021. Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma. Biochemistry and Biophysics Reports. 27 101081. https://doi.org/10.1016/j.bbrep.2021.101081

The presence of Y674/Y675 phosphorylated NTRK1 via TP53 repression of PTPN6 expression as a potential prognostic marker in neuroblastoma
Youssef, G., Gillett, C., Rampling, D., Chagtai, T., Virasami, A., Barton, J., Edwards, D., Sebire, N., Anderson, J. and Montano, X. 2019. The presence of Y674/Y675 phosphorylated NTRK1 via TP53 repression of PTPN6 expression as a potential prognostic marker in neuroblastoma. Human Pathology. 86, pp. 182-192. https://doi.org/10.1016/j.humpath.2018.12.003

A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma
Dvorkina, M., Nieddu, V., Chakelam, S., Pezzolo, A., Cantilena, S., Leite, A.P., Chayka, O., Regad, T., Pistorio, A., Sementa, A.R., Virasami, A., Barton, A., Montano, X., Lechertier, T., Brindle, N., Morgenstern, D., Lebras, M., Burns, A.J., Saunders N.J., Hodivala-Dilke, K., Bagella, L., De The, H., Anderson, J., Sebire, N., Pistoia, V., Sala, A. and Salomoni, P. 2016. A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma. Clinical Cancer Research. 22 (13), pp. 3398-3409. https://doi.org/10.1158/1078-0432.CCR-15-2081

Phosphorylation of NTRK1 at Y674/Y675 induced by TP53-dependent repression of PTPN6 expression: a potential novel prognostic marker for breast cancer
Youssef, G., Gillett, C., Agbaje, O., Crompton, T. and Montano Hernandez, X. 2014. Phosphorylation of NTRK1 at Y674/Y675 induced by TP53-dependent repression of PTPN6 expression: a potential novel prognostic marker for breast cancer. Modern Pathology. 27, pp. 361-374 23948750. https://doi.org/10.1038/modpathol.2013.129

Epidermal growth factor upregulates motility of Mat-LyLu rat prostate cancer cells partially via voltage-gated Na+ channel activity
Ding, Y., Brackenbury, W.J., Uysal Onganer, P., Montano, Ximena, Porter, L.M., Bates, L.F. and Djamgoz, M.B.A. 2008. Epidermal growth factor upregulates motility of Mat-LyLu rat prostate cancer cells partially via voltage-gated Na+ channel activity. Journal of Cellular Physiology. 215 (1), pp. 77-81. https://doi.org/10.1002/jcp.21289

Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer
Montano, Ximena and Djamgoz, Mustafa B.A. 2004. Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer. FEBS Letters. 571, pp. 1-3. https://doi.org/10.1016/j.febslet.2004.06.088

Analysis of trk A tyrosine kinase and p53 association
Browes, C., Rowe, J., Brown, A. and Montano, Ximena 2001. Analysis of trk A tyrosine kinase and p53 association. FEBS Letters. 497, pp. 20-25. https://doi.org/10.1016/s0014-5793(01)02429-2

Common amino acid sequence motifs in p53, 14-3-3 and Akt protein families
Montano, Ximena 2001. Common amino acid sequence motifs in p53, 14-3-3 and Akt protein families. FEBS Letters. 507 (2), pp. 237-240. https://doi.org/10.1016/S0014-5793(01)02903-9

c-abl is involved in the association of p53 and trk A
Montano, Ximena 2000. c-abl is involved in the association of p53 and trk A. Oncogene. 19, pp. 3032-3040. https://doi.org/10.1038/sj.onc.1203619

Permalink - https://westminsterresearch.westminster.ac.uk/item/w9965/repression-of-shp-1-expression-by-p53-leads-to-trka-tyrosine-phosphorylation-and-suppression-of-breast-cancer-cell-proliferation


Share this

Usage statistics

43 total views
0 total downloads
These values cover views and downloads from WestminsterResearch and are for the period from September 2nd 2018, when this repository was created.